Published in Clin Exp Immunol on June 01, 1982
Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ (2000) 7.36
Anesthetics, immune cells, and immune responses. J Anesth (2008) 1.27
Regional vs general anaesthesia in orthopaedics. Can J Anaesth (1993) 0.83
Differences in stress response between patients undergoing transurethral resection versus endoscopic laser ablation of the prostate for benign prostatic hyperplasia. Lasers Med Sci (2007) 0.75
Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med (1972) 24.43
Postoperative depression of the lymphocyte response to phytohaemagglutinin. Lancet (1967) 2.57
Immunodepression after major surgery in normal patients. Surgery (1975) 2.48
Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J (1972) 1.84
The effect of anaesthesia on the lymphocyte response to phytohaemagglutinin. Clin Exp Immunol (1974) 1.37
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
Lymphocyte transformation and changes in leukocyte count: effects of anesthesia and operation. Anesthesiology (1975) 1.01
Combined T and B lymphocyte marker test in lymphoproliferative disorders. Br J Haematol (1977) 0.90
Reversal of postoperative immunosuppression in man by vitamin A. Surg Gynecol Obstet (1979) 0.89
Biometrical implications of factorial experiments for the study of lymphocyte mitogenic response. J Immunol Methods (1977) 0.85
Reliability of plasma cortisol determination by a simple competitive protein binding method. Ann Clin Biochem (1976) 0.83
Failure of enflurane and halothane anesthesia to inhibit lymphocyte transformation in volunteers. Anesthesiology (1976) 0.80
In vitro technique for isolating prostatic cells from blood. J Surg Res (1979) 0.79
Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens (1995) 6.33
Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med (1990) 4.48
Legionnaires' disease in a transplant unit: isolation of the causative agent from shower baths. Lancet (1980) 4.04
Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med (1990) 3.73
"Hyperacute" renal-homograft rejection in man. N Engl J Med (1968) 3.37
Organisation of vascular surgical services: evolution or revolution? BMJ (1994) 3.28
IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol (2001) 3.22
Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med (1995) 3.16
Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone. J Exp Med (1988) 2.98
Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues. J Exp Med (1988) 2.73
Association of autoimmune active chronic hepatitis with HL-A1,8. Lancet (1972) 2.69
Urological complications in 1,000 consecutive renal transplant recipients. J Urol (1995) 2.48
The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation (1984) 2.45
The survival of patients with colorectal cancer treated in a regional hospital. Br J Surg (1978) 2.27
The detailed distribution of MHC Class II antigens in normal human organs. Transplantation (1984) 2.26
Systemic cytokine response after major surgery. Br J Surg (1992) 2.23
Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts. Transplantation (1980) 2.21
Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis. Am J Transplant (2012) 2.18
Surgical management of the thoracic outlet compression syndrome. Br J Surg (1991) 2.13
Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen. Clin Exp Immunol (1980) 2.12
Dipstick haematuria and bladder cancer in men over 60: results of a community study. BMJ (1989) 1.95
Carotid endarterectomy in Great Britain and Ireland. Br J Surg (1986) 1.90
Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type. Diabetes (1977) 1.88
Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation (1986) 1.88
A mixed culture recovery method indicates that enteric bacteria do not enter the viable but nonculturable state. Appl Environ Microbiol (1998) 1.85
Pancreaticoduodenal cancer. Experience from 1951 to 1960 with a look ahead and behind. Arch Surg (1966) 1.83
Cyclosporin A. Transplantation (1981) 1.72
Provision of vascular surgical services in the Oxford Region. Br J Surg (1994) 1.65
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol (1996) 1.63
Recovery of hydrogen peroxide-sensitive culturable cells of Vibrio vulnificus gives the appearance of resuscitation from a viable but nonculturable state. J Bacteriol (2000) 1.63
Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med (1991) 1.62
Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center. Eur Urol (1998) 1.61
A method for isolation of islets of Langerhans from the human pancreas. Diabetes (1984) 1.60
Distribution and quantitation of HLA-ABC and DR (Ia) antigens on human kidney and other tissues. Transplantation (1980) 1.59
Donor-recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor-specific transfusion and anti-CD4 antibody. Evidence of a clear role for short-term antigen persistence. Transplantation (1995) 1.58
myo-inositol pentakisphosphates. Structure, biological occurrence and phosphorylation to myo-inositol hexakisphosphate. Biochem J (1991) 1.57
Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet (1996) 1.54
Long-term follow-up after weight management in obese dogs: the role of diet in preventing regain. Vet J (2011) 1.53
Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics. Diabetes (1982) 1.53
The effect of smoking on the late patency of arterial reconstructions in the legs. Br J Surg (1978) 1.51
Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial. Eur J Vasc Endovasc Surg (1996) 1.51
Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation (2004) 1.51
The mortality of abdominal aortic aneurysm. Ann R Coll Surg Engl (1986) 1.50
T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors. Eur J Immunol (1986) 1.49
The urological complications of renal transplantation: a series of 1535 patients. BJU Int (2002) 1.48
Upper gastrointestinal haemorrhage in Oxford. A prospective study. J R Coll Surg Edinb (1984) 1.48
Death of the Escherichia coli K-12 strain W3110 in soil and water. Appl Environ Microbiol (1996) 1.46
Portal endotoxin and cytokine responses during abdominal aortic surgery. Am J Surg (1993) 1.45
Effector mechanisms in allograft rejection. Annu Rev Immunol (1986) 1.43
The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation (1972) 1.40
Isolation and characterization of dendritic cells from mouse heart and kidney. J Immunol (1994) 1.40
Carotid duplex scanning: patterns of referral and outcome. Eur J Vasc Endovasc Surg (1995) 1.40
Role of transplantation in the management of hepatic malignancy. Br J Surg (2007) 1.40
Auditing the vascular surgical audit. Br J Surg (1987) 1.39
Intravesical mitozantrone in recurrent superficial bladder cancer: a phase II study. Br J Urol (1995) 1.39
Reprinted article "Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial". Eur J Vasc Endovasc Surg (2011) 1.38
Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipients. Transplantation (1994) 1.37
Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer. Oncology (2005) 1.34
Localization of major histocompatibility complex (HLA-ABC and DR) antigens in 46 kidneys. Differences in HLA-DR staining of tubules among kidneys. Transplantation (1983) 1.32
Carotid endarterectomy in Great Britain and Ireland: practice between 1984 and 1992. Br J Surg (1994) 1.31
A technique for lymphocyte preparation from stored heparinized blood. Vox Sang (1971) 1.31
Developments in isolated pancreatic islet transplantation. Transplantation (1987) 1.30
Wound dehiscence. A continuing problem in abdominal surgery. Arch Surg (1966) 1.29
Matching for HLA in transplantation. Br Med Bull (1978) 1.27
Trends in management of acute cholecystitis. Br Med J (Clin Res Ed) (1982) 1.25
Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med (1991) 1.23
Urological complications in 600 consecutive renal transplants. Br J Surg (1987) 1.23
Renal transplantation in the rat: details of a technique. Aust N Z J Surg (1971) 1.23
p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J Biol Chem (1999) 1.22
Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs. Domest Anim Endocrinol (2009) 1.20
Localization of HLA-ABC and DR antigens in human kidney. Transplantation (1981) 1.19
HLA and pancreatic islet cell antibodies in diabetes. Lancet (1976) 1.18
Muscle metabolism in patients with peripheral vascular disease investigated by 31P nuclear magnetic resonance spectroscopy. Clin Sci (Lond) (1986) 1.17
Inability of dendritic cells to prevent the blood transfusion effect in a mouse cardiac allograft model. Transplantation (1987) 1.17
Quality of life is reduced in obese dogs but improves after successful weight loss. Vet J (2011) 1.16
Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol (2001) 1.16
Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome. Transplantation (1989) 1.16
CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection. J Immunol (2000) 1.15
Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg (1992) 1.14
Letter: A possible association between paralytic poliomyelitis and multiple sclerosis. Lancet (1973) 1.14
Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma. Ann Surg Oncol (2008) 1.14
Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation. Lancet (1987) 1.13
Leucocyte antigens in Hodgkin's disease. Lancet (1970) 1.13
Segmental small intestinal allografts in the dog. I. Morphological and functional indices of rejection. Transplantation (1987) 1.13
Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys--correlation with intragraft events. Transplantation (1993) 1.12
Mechanisms of allograft rejection: the roles of cytotoxic T-cells and delayed-type hypersensitivity. Immunol Rev (1984) 1.12
Immediate renal-graft biopsy and subsequent rejection. Lancet (1968) 1.12
A technique for transplanting pancreatic islets as a vascularized graft and prevention of rejection with cyclosporin A. Transplantation (1981) 1.11
Serotyping for homotransplantation. XII. Occurrence of cytotoxic antibodies following kidney transplantation in man. Transplantation (1968) 1.11
Studies on the effects of cyclosporin A upon renal allograft rejection in the dog. Surgery (1980) 1.11
Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion. Am J Pathol (1998) 1.11
Recurrent inguinal hernia after local anaesthetic repair. Br J Surg (1981) 1.10
Failure of specific active immunotherapy in lung cancer. Br J Cancer (1981) 1.09
A pilot study of intermittent androgen deprivation in advanced prostate cancer. Br J Urol (1998) 1.08
Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Transplantation (1992) 1.08
Prostaglandin E1 in severe lower limb ischaemia: a double-blind controlled trial. Br J Surg (1984) 1.08
Problems facing the society today. Transplant Proc (1987) 1.08
Cadaveric renal transplantation. Lancet (1968) 1.07
Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4+ T cell regulation during the induction phase of the response. Eur J Immunol (1995) 1.07
Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine. Transplantation (1983) 1.07